Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Carma Labs’ Carmex Cold Sore Treatment claims did not mirror language in two OTC monographs for its active ingredients, the National Advertising Division says in a review of packaging and advertising claims challenged by GlaxoSmithKline's consumer business.